Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06133920 · ClinicalTrials.gov registry record

Duration of Immobilization After Reverse Total Arthroplasty for Proximal Humerus Fractures

A clinical trial of Reverse Total Shoulder Arthroplasty and Proximal Humeral Fracture, sponsored by The Cooper Health System.

Recruiting
Registry status
40
Enrollment target
1
Study location

NCT06133920 is a study of Reverse Total Shoulder Arthroplasty and Proximal Humeral Fracture that is actively recruiting participants, run by The Cooper Health System. The registered enrollment target is 40 participants, below the 236-participant average among 3 other Reverse Total Shoulder Arthroplasty trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06133920, a study of Reverse Total Shoulder Arthroplasty and Proximal Humeral Fracture, is actively recruiting participants, sponsored by The Cooper Health System.

RECRUITING
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate compare postoperative range of motion in patients who are given a sling for comfort only and allowed to start early active range of motion compared to patients who are placed in a sling for 4 weeks with passive range of motion only. Once enrolled, the patients will be randomized through computer randomization then placed in paper packets into either the immobilization group or the early range of motion group.

Interventions

  • OTHER Early Range of Motion
  • OTHER Immobilization

Study Locations (1)

New Jersey

  • Cooper University Hospital - Camden

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2021-02-24
Est. Completion 2027-02-01

Sponsor

The Cooper Health System

39 total trials

What the Registry Record Tells You About NCT06133920

The ClinicalTrials.gov registry entry for NCT06133920 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 236-participant average among 3 other Reverse Total Shoulder Arthroplasty trials with a reported enrollment target (83% lower). The listed sponsor is The Cooper Health System, which has 39 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Reverse Total Shoulder Arthroplasty appearing as the primary indexed condition, and to 2 interventions - of which Early Range of Motion is the first listed.

NCT06133920 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT06133920 about?

NCT06133920 is a clinical study titled "Duration of Immobilization After Reverse Total Arthroplasty for Proximal Humerus Fractures". The purpose of this study is to evaluate compare postoperative range of motion in patients who are given a sling for comfort only and allowed to start early active range of motion compared to patients who are placed in a sling for 4 weeks with passive range of motion only. Once enrolled, the patient...

What is the current status of trial NCT06133920?

This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2021-02-24. Estimated completion is 2027-02-01.

What conditions does trial NCT06133920 study?

This clinical trial studies the following conditions: Reverse Total Shoulder Arthroplasty, Proximal Humeral Fracture.

What interventions are being tested in trial NCT06133920?

The interventions under investigation include: Early Range of Motion (OTHER), Immobilization (OTHER).

Who is sponsoring clinical trial NCT06133920?

This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06133920 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Reverse Total Shoulder Arthroplasty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.